1. Home
  2. TRDA vs CODI Comparison

TRDA vs CODI Comparison

Compare TRDA & CODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$12.68

Market Cap

438.8M

Sector

Health Care

ML Signal

HOLD

Logo D/B/A Compass Diversified Holdings Shares of Beneficial Interest

CODI

D/B/A Compass Diversified Holdings Shares of Beneficial Interest

HOLD

Current Price

$6.33

Market Cap

480.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRDA
CODI
Founded
2016
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
438.8M
480.8M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
TRDA
CODI
Price
$12.68
$6.33
Analyst Decision
Strong Buy
Hold
Analyst Count
2
1
Target Price
$20.00
$8.00
AVG Volume (30 Days)
189.4K
1.2M
Earning Date
05-25-2026
01-01-0001
Dividend Yield
N/A
3.64%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$25,421,000.00
N/A
Revenue This Year
$51.37
$0.93
Revenue Next Year
$46.98
$6.35
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.93
$4.58
52 Week High
$12.93
$20.07

Technical Indicators

Market Signals
Indicator
TRDA
CODI
Relative Strength Index (RSI) 59.74 42.19
Support Level $9.59 $6.15
Resistance Level N/A $7.33
Average True Range (ATR) 0.84 0.56
MACD 0.07 -0.16
Stochastic Oscillator 85.96 0.24

Price Performance

Historical Comparison
TRDA
CODI

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

About CODI D/B/A Compass Diversified Holdings Shares of Beneficial Interest

Compass Diversified Holdings is a diversified business conglomerate based in the United States having two groups: branded consumer business and industrial business. Branded consumer businesses are characterized as those businesses that capitalize on a valuable brand name in their respective market sector. It includes 5.11, Ergobaby, Liberty Safe, and Velocity Outdoor. Industrial businesses are characterized as those businesses that focus on manufacturing and selling particular products and industrial services within a specific market sector. The company has operations in the United States, Canada, Europe, Asia Pacific, and other International areas.

Share on Social Networks: